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ABSTRACT 
Objective: The aim of this study was to examine the role of NT-3 as a single neurotrophic factor in the expression of nestin in the neural 
differentiation of MSCs.  
Methods: MSCs were isolated from rat bone marrow and induced with NT-3 at concentrations of 20, 25, and 30 ng/ml for 7 and 14 d (the control 
was no NT-3). Nestin underwent immunocytochemical analysis on days 7 and 14. Five high-power random fields were documented.  
Results: A post-hoc analysis using LSD after one-way ANOVA test yielded a statistically significant difference in the percentage of nestin-positive 
cells in MSCs with NT-3 at concentrations of 20, 25, and 30 ng/ml for 7 d compared to the control group (p<0.05). The percentages of nestin-
positive cells at concentrations of 20, 25, and 30 ng/ml, and in the control data on day 7 were 14.55±1.26%, 16.20±1.07%, 13.78±1.19%, and 
9.81±0.79%, respectively. NT-3 at 25 ng/ml induced the highest MSCs neural differentiation on day 7 and remained constant until day 14.  
Conclusion: NT-3 plays a role in the early stage of differentiating MSCs from rat bone marrow into neurons, with the optimal concentration being 
25 ng/ml.  
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Stroke is a cause of death amongst Indonesian citizens (>15 y old) 
that contributes to 15.4% of the total mortality rate (Riskesdas 
2007) [1]. The prevalence of stroke increased to 12.1 per 1000 
people in 2013, up from 8.3 per 1000 people in 2007 (Riskesdas 
2013) [2]. Despite the advances in drugs that salvage the penumbra 
area of the brain, the stroke area succumbs from irreversible 
damage. Post-stroke neuronal deficit frequently occurs due to the 
limited capacity of the brain for neural regeneration [3]. Post-stroke 
neuronal deficits can potentially be recovered by stem cell 
transplantation. The capacity of stem cells to self-renew and to 
maintain stemness thus holds the potential for further 
differentiation into other lineages, including osteoblasts, 
chondrocytes, adipocytes, and neurons [4-5]. 
In vitro differentiation of mesenchymal stem cells (MSCs) into 
neurons has been reported by the combination of several growth 
factors, including basic fibroblast growth factor (bFGF), epidermal 
growth factor (EGF), insulin-like growth factor-1 (IGF-1), bone 
morphogenetic protein-4 (BMP4), fibroblast growth factor-8 (FGF-
8). Other chemical substances, such as β-mercaptoethanol (BME), 
retinoic acid (RA), and forskolin (FSK), were also reported to induce 
differentiation into neurons [6, 7]. In addition, neurotrophic factors, 
such as nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), and neurotrophin-3 (NT-3), were successfully 
documented as influencing in vitro differentiation of neural stem 
cells and MSCs into neurons [7, 8].  
Neurotrophin-3 (NT-3), hippocampus-derived neurotrophic factor 
(HDNF), and NGF-2 each have a molecular weight of 13.6 kDa, which 
is identical to that of NGF and BDNF. NT-3 is a protein member of the 
neurotrophin family that plays a role in neuronal survival, growth, 
and differentiation [9]. Neurotrophin also regulates synaptic 
structure, connection, neuroprotection, the growth of axons and 
dendrites, and glial cell development [10, 11]. Zhu et al. (2012) 
reported that NT-3 contributes to the differentiation of neuronal 
stem cells of rats into neurons and oligodendrocytes at 16 d of 
gestation [6]. In addition, Guan et al. (2014) demonstrated that MSCs 
from rat bone marrow could differentiate into neurons using a 
combination of growth factors, i.e., EGF, bFGF, IGF-1, and NT-3 [8]. 
A combination of growth and neurotrophic factors consistently 
showed efficacy in neural differentiation protocols. However, the 
role of each factor, particularly NT-3 as a single neurotrophic factor, 
in MSCs neural differentiation is not yet completely understood. The 
aim of this study is to examine the role of NT-3 as a single 
neurotrophic factor in the expression of nestin in the neural 
differentiation of MSCs, in order to provide basic theoretical data for 
further research in managing neurodegeneration.  
MATERIALS AND METHODS 
Methods 
This study was conducted from February to November 2016 at the Stem 
Cell Laboratory, Center for Research and Development of Biomedical and 
Basic Health Technology (CRDBBHT), National Institute of Health 
Research and Development (NIHRD), Ministry of Health in our country 
and at the Histology Laboratory in our university.  
Isolation, culture, and characterization of MSCs from rat bone 
marrow aspirate  
All procedures for handling rats were in compliance with the local 
animal welfare facility rules and were approved by the Ethics 
Committee FMUI no. 208/UN2. F1/ETIK/2016. Twelve Sprague 
Dawley rats (Rattus norvegicus L) from the Animal Laboratory, 
CRDBBHT NIHRD, aged 2–4 mo, and weighing 200–300 g were used 
in this study. Rats were anesthetized via intraperitoneal injection 
using a ketamine dose of 75–100 mg/kg in a mixture with a xylazine 
dose of 5–10 mg/kg in order to obtain the femur and tibia bones.  
MSCs were isolated from the femur and tibia bones by following a 
modification of the method of Rinendyaputri et al. (2015) [12] by 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                    Vol 12, Special Issue 3, 2020 
Antarianto et al. 
Int J App Pharm, Vol 12, Special Issue 3, 2020, 44-49 
4th International Conference and Exhibition on Indonesian Medical Education and Research Institute 2019                                           | 45 
adding povidone-iodine to decontaminate bones. First, the bones 
were immersed in 1% povidone-iodine solution and 70% ethanol 
antiseptic on a separate petri dish for two minutes. In addition, the 
attached fat and connective tissue were removed using a pair of 
tweezers and a scalpel. The bones were then immersed in 
Dulbecco’s® phosphate-buffered saline (PBS) solution, prepared by 
diluting PBS 10x (Sigma®) 1:10 in Milli-Q water and filtering through 
a 0.2 mm sterile filter. Each bone end was sectioned using a pair of 
tweezers and scissors until the bone marrow was exposed. 
Subsequently, bone marrow aspirate was flushed using a 3 ml 
syringe that contained Eagle’s® minimum essential medium-MEM 
(Sigma®) supplemented with penicillin-streptomycin (10,000 U/ml) 
(Gibco®) and 10% fetal bovine serum-FBS (Gibco®) into a petri dish 
while the bone was stabilized using a pair of tweezers. Then the 
aspirate incubated in a 5% CO2 incubator (Heracell Vios 160i) at 37 
°C. After 24 h, the medium was discarded. The subsequent medium 
was changed every 2–3 d.  
Passages were initiated after the cell confluence reached 
approximately 70–80%. Passage 4 (P4) was used for the 
immunophenotype analysis, the differentiation assay, and the 
induction of neural differentiation. Immunophenotype analysis of 
MSCs markers with anti-CD29-fluorescein isothiocyanate (FITC), 
CD90-allophycocyanin (APC), and CD45-phycoerythrin (PE), all three 
provided from Biolegend®, was conducted using a flow cytometer (BD 
FACSCalibur®). A differentiation assay was performed according to the 
protocol supplied by the StemPro Adipocyte Differentiation Kit, 
StemPro Chondrogenesis Differentiation Kit, and StemPro 
Osteogenesis Differentiation Kit (all kits by Gibco®). 
Induction of MSCs neural differentiation with NT-3 
The induction methods of MSCs neural differentiation were modified 
from those of Guan et al. (2014) by changing Dulbecco’s modified 
Eagle’s medium with low glucose to MEM [9]. MSCs P3 was 
harvested by trypsinization using trypsin 
ethylenediaminetetraacetic acid-EDTA (Gibco®) and centrifuged. 
The pellet was resuspended in the induction medium (MEM-Sigma) 
containing 2% FBS (Gibco®) and 1% N-2 supplements (Gibco®). NT-
3 (Sigma®) was added to the induction medium to obtain a final 
concentration of 20, 25, or 30 ng/ml in each well. The NT-3 
concentration was optimized by a gradient dose concentration from 
0–60 ng/ml (Appendix 1). The control well was cultured using a 
basic induction medium (MEM+2% FBS+1% N2). The MSCs were 
seeded on 24 well culture plates with a final cell density of 2×104/ml 
and incubated in a 5% CO2 incubator at 37 °C. MSCs treated with 
three different concentrations of NT-3 were cultured in triplicates, 
respectively. The induction medium (with or without NT-3 
supplementation) was replaced every 2–3 d. The induced MSCs were 
observed under a Nikon inverted microscope (ECLIPSE TE2000-U 
with Imaging Software NIS-Elements F Version 4.30.01). The 
immunocytochemical analysis of the nestin was conducted at day 7 
and day 14. 
The nestin immunocytochemistry of the induced MSCs  
The immunocytochemical analysis of the MSCs induced neural 
differentiation was modified from Stephanie et al. (2013) by 
decreasing the time of incubation of the MSCs seeded on the well 
plate [13]. The culture medium was discarded from the well, leaving 
only the attached MSCs on the well-plate surface. These MSCs were 
then rinsed with PBS twice. The MSCs fixation was done by 
incubating these cells in 4% paraformaldehyde (PFA) for 15 min and 
then they were rinsed with PBS 3 times each for 5 min. We 
performed blocking steps in order to inhibit endogenous cell 
peroxidase so that this enzyme will not impair the staining process. 
This procedure was carried out using 3% (v/v) H2O2 in methanol 
(Merck®) for 15 min and (ii) blocking of nonspecific background 
staining with a background snipper (Starr Trek Universal HRP 
Detection Kit Biocare®) for 15 min. The blocking reagents were then 
discarded and MSCs were rinsed three times in PBS for 5 min each 
time, then incubated with nestin primary antibody (Santa Cruz®) at 
4 °C overnight. The next day, the same cells were rinsed again three 
times in PBS for 5 min each time. Further incubation with a 
secondary horseradish peroxidase (HRP)-conjugated antibody 
(Trekkie Universal Link, Starr Trek Universal HRP Detection Kit 
Biocare®) lasted for 15 min and then these cells were rinsed in PBS 
for 5 min. After that, incubation with Trek-Avidin-HRP (Starr Trek 
Universal HRP Detection Kit Biocare®) took place for 15 min and 
then they were rinsed in PBS for 5 min. The chromogen substrate 
diaminobenzidine (DAB) dissolved in substrate buffer (Starr Trek 
Universal HRP Detection Kit Biocare®) was added into the cells for 
1–2 min, and then these were rinsed with Milli-Q water for 10 min. 
After removal of Milli-Q water, these cells were counterstained with 
Hematoxylin Mayer (Biocare® 3570) for 1–2 min and finally rinsed 
in Milli-Q water for 5 min.  
Positive and negative controls were included in every staining 
protocol. The positive control for nestin immunocytochemistry was 
the primary isolated neuron culture from the rat brain. Nestin-
positive cells were indicated by a brown color in the cytoplasmic and 
nucleus area. The negative control was the immunocytochemistry 
protocol without the nestin primary antibody incubation. Nestin-
negative cells appeared as cells with a bluish stained nucleus or a 
hematoxylin stained nucleus.  
Nestin tissue expression data analysis 
Nestin-positive cells were counted in triplicates from five randomly 
assigned high power magnification 400x fields. Images were 
documented under a Nikon inverted microscope (ECLIPSE TE2000-U) 
and Software Image Raster version 3.0 was used to calculate the number 
of cells tagged by the investigator. Nestin-positive cells (expressed in the 
nucleus and cytoplasm) and nestin-negative cells were tagged and 
counted by two investigators without prior knowledge of the sample 
label (double-blind). The percentages of nestin-positive and negative 
cells were measured from two sets of observations.  
Data analysis  
The percentages of nestin-positive and nestin-negative cells were 
compared among different experiment groups through a one-way 
analysis of ANOVA using Statistical Product and Service Solution 
(SPSS) 16. Post-Hoc analysis using LSD was performed to determine 
which pair groups carrying significant association. Significant 
differences are indicated as p<0.05. The results are provided as the 
mean±the standard error of the mean. 
RESULTS 




Fig. 1: Morphology of primary MSCs isolated from rat bone 
marrow, (A) Culture of MSCs isolated from rat bone marrow, 
day 0 (magnification 400x). The arrow indicates erythrocytes, 
(B) Culture of MSCs from rat bone marrow, day 1 (magnification 
100x), (C) Culture of MSCs from rat bone marrow, day 5 
(magnification 100x), (D) Culture of MSCs from rat bone 
marrow, day 8 (magnification 100x) 
 
The isolation of MSCs from rat bone marrow initially showed a 
heterogeneous cell population, which was gradually populated by 
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MSCs-like morphology. On day 0, the cells in the primary bone 
marrow aspirate culture were globules of different sizes and were 
well distributed, and erythrocytes were still present in the well (the 
arrow in fig. 1A). On day 1, the cells started to attach to the culture 
well (fig. 1B). On day 5, the cells showed fibroblastic
shaped forms and the other cells showed globular cell forms of 
 
Fig. 2: (A) Differentiation potency of MSCs from bone marro
arrow) (magnification 100x); (B) chondrocyte with a specific proteoglycan of cartilage (red arrow) (magnification 40x); (C) 
with lipid droplets inside the adipocyte cytoplasm (black arrow) (magnification 400x); (D) and phenotype of MSCs from bone ma
The differentiation potency of the MSCs was tested using a 
commercially available kit [14]. The MSCs isolated from the rat 
bone marrow were able to differentiate into osteoblasts, 
chondrocytes, and adipocytes. A histology analysis revealed the 
presence of calcium in the extracellular matrix by alizarin red 
staining, the presence of chondrocyte extracellular matrix by 
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-like or spindle-
comparable size (fig. 1C). On day 8, the cells attached to the culture 
well as a single layer and reached confluency (
the standard MSCs morphology, 
observed. Subsequent passages were done until passage 4 in order 
to obtain an adequate number of cells for the experiments on 
inducing MSCs neural differentiation.
w: osteoblast with the presence of calcium in the extracellular matrix (blue 
with flow cytometry analysis 
 
alcian blue staining and the presence of lipid droplets inside the 
adipocyte cytoplasm by oil red O staining (
characteristics of the immunophenotyp
marrow using flow cytometry analysis showed 99.97% 
CD29+CD90+(MSCs marker) and 1.55% CD45+
(hematopoietic markers) (fig. 2D).
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fig. 1D). At this point, 





fig. 2A, B, and C). The 
e of MSCs-P4 from bone 
/low 
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NT-3 at 25 ng/ml induced the highest MSCs neural differentiation on day 7 and was stationary on day 14 
Fig. 3: Immunocytochemical analysis of nestin from day 7 (A
3 at 0 ng/ml; (D, J) NT-3 at 20 ng/ml; (E, K) NT
Fig. 4: Mean percentages of nestin-positive cells on day 7 (black histogram) and on day 14 (grey histogram). The error bar ind
standard error of the mean (SEM), *represents a statistically significant difference, p
The histological images of induced MSCs neural differentiation 
observed on day 7 and day 14 for NT-3 at 20 ng/ml (fig. 3D and 4J), 
at 25 ng/ml (fig. 3E and 3K), and at 30 ng/ml (fig. 3F, 3L), for no NT
3 (fig. 3C and 3I), for the positive control (fig. 3A and 3G), and for the 
negative control (fig. 3B and 3H). 
Compared to the control group (NT-3 at 0 ng
percentages of nestin-positive cells treated with NT
ng/ml increased by 1.48 fold, 1.65 fold, and 1.4 fold, respectively (
4). The percentages of nestin-positive cells at concentra
25, and 30 ng/ml, and in the control data on day 7 were 
14.55±1.26%, 16.20±1.07%, 13.78±1.19%, and 9.81±0.79%. Hence, 
the highest increment in the percentage of nestin
day 7 was achieved with the addition of NT-
Post-Hoc analysis using Least Significant Difference (LSD), n
expression on day 7 produced a statistically significant difference 
between the control group and the groups with additional NT
20, 25, and 30 ng/ml (p<0.05). 
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–F) and day 14 (G–L); (A, G) positive contro




<0.05 (n=15, compared with NT




/ml) on day 7, 
-3 at 20, 25, 30 
fig. 
tions of 20, 
-positive cells on 
3 at 25 ng/ml. After 
estin 
-3 at 
Meanwhile, on day 14, the mean percentages of nestin
with additional NT-3 at 20, 25, and 30 ng
control group (NT-3 0 ng/ml) showed increments ranging only from 
1.09-fold to 1.17-fold. The percentages of nestin
concentrations of 20, 25, and 30 ng
day 14 were 10.65±0.56%, 10.59±0.55%, 11.42±0.72%, and 
9.71±0.47%. Using the same Post
significance (p<0.05) was only observed between 
treatment group with NT-3 addition at 30 ng
as illustrated in fig. 4, the mean percentages of nestin
on day 14 yielded lower proportions of nestin
respectively for each group compared to those on day 7.
DISCUSSION 
In this study, isolated MSCs from rat bone marrow aspirates were 
successfully maintained. The cell population expressed the MSCs 
markers CD29+/high, CD90+/high, and CD45
Special Issue 3, 2020, 44-49 
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revealed the ability of MSCs to differentiate into osteoblasts, 
chondrocytes, and adipocytes. Indeed, the MSCs used in this study 
showed conformity to standard rat bone marrow MSCs [15]. 
Inducing MSCs neural differentiation with additional NT-3 in 
combination with NGF and BDNF has been reported by Jahani et al. 
(2015) [16] and Kil et al. (2016) [17], also in combination with other 
growth factors, such as epidermal growth factor (EGF) and basic 
fibroblast growth factor (bFGF) IGF-1 [6]. This study investigated the 
role of NT-3 as a single neurotrophic factor in inducing MSCs neural 
differentiation. It is important to investigate NT-3 as a single 
neurotrophic factor in order to determine the significance of the 
factors that induce MSCs' neural differentiation. Induced MSCs neural 
differentiation was indicated by gradual changes in the induced MSCs 
morphology into polarized neuron structures, such as the formation of 
axons and dendrites that projected from the neuron soma or as 
connections between axons and dendrites (synapse formation).  
Confirmation of neural differentiation requires neural differentiation 
markers. Nestin is well known as an intermediate filament protein in 
mammalian brain neural stem cells and neural progenitor cells 
during the early development of the central nervous system and 
proliferating neuroepithelial cells [18–20]. Wiese et al. (2004) [21] 
and Lindsay et al. (2016) [22] suggested nestin as a marker of 
progenitor cell multipotency. This study used nestin as a marker for 
the early stages of neural differentiation.  
Nestin expression on day 7 produced a statistically significant 
difference between the control group and treated groups with NT-3 
addition at 20, 25, and 30 ng/ml. This result indicates the 
importance of additional NT-3 in early-stage induced MSCs neural 
differentiation (7 d). The highest mean percentage of nestin-positive 
cells was obtained with additional NT-3 at 25 ng/ml. 
The percentage of nestin-positive cells on day 7 was in line with the 
results from the study by Jeon et al. (2007) [23]. They showed 
induced MSCs neural differentiation with additional NT-3 at 30 
ng/ml and bFGF at 10 ng/ml after 7 d; they obtained 14.2±2.0% as 
the percentage of nestin-positive cells.  
The percentage of nestin-positive cells observed in this study was 
lower than that reported by Zhu et al. (2012) [6] because of different 
sources of MSCs. Zhu et al. induced primary isolated neural stem 
cells from the rat brain, while our study used MSCs from rat bone 
marrow. Neural stem cells have a more direct tendency to 
differentiate into neuro-ectodermal cell lines. Thus, inducing MSCs, 
which are of mesodermal characteristics, into neural cells, requires 
some alteration from their inherent differentiation pattern. 
The results of our study support the role of NT-3 as a single 
neurotrophic factor that regulates early-stage neural differentiation. 
The signaling pathway regulated by NT-3 during neural 
differentiation has been elucidated in several studies [22–26]. NT-3 
binds to the receptor neurotrophin tyrosine kinase (TrkC), which 
subsequently induces transphosphorylation of intracellular tyrosine 
residue and binds to Shc (Src [Rous sarcoma oncogene cellular 
homolog-an intracellular protein-tyrosine kinase lacking direct 
contact with extracellular signaling molecules] homology 2 domain-
containing). NT-3 binds to other domains of the receptor, which 
activates growth factor receptor-bound protein 2 (Grb2), which 
binds to Sos (son of sevenless guanine nucleotide exchange factor) 
and subsequently forms a complex with Shc as Grb2-Sos-Shc. This 
complex activates Ras (oncogene protein P21), which then activates 
rapidly accelerated fibrosarcoma 1 (Raf-1) and the phosphorylates 
MAP/ERK kinase (MEK1) pathway. This pathway plays a significant 
role in cell survival, proliferation, and differentiation. Differentiation 
of embryonic stem cells and neural stem cells into neurons is 
regulated by this pathway [24,25].  
In order to determine the optimum NT-3 concentration, this study 
initially used gradient dose concentration and compared each dose 
concentration to the percentage of viable MSCs in the well (data not 
shown). Further study is required to confirm which signaling 
pathway of NT-3 induced MSCs early-stage neural differentiation. 
There was little effect of NT-3 on inducing MSCs neural differentiation 
after day 7. Extension of additional NT-3 in inducing MSCs neural 
differentiation from day 7 until day 14 showed a lower percentage of 
nestin-positive cells on day 14 than day 7. This result was in line with a 
study by Zhu et al. that showed a lower percentage of nestin-positive 
cells after additional NT-3 up to 14 d. The decrease in the percentage 
of nestin-positive cells is explained by the concurrent increase in the 
percentage of terminally differentiated neuron/glial cells.  
The limitation of this study was the lack of a specific marker for 
terminally differentiated neuron/glial cells. Thus, we recommend 
further evaluation of the NT-3 role in terminal differentiation of 
specific neuron/glial cells (astrocytes and oligodendrocytes) by 
additional markers, e. g., MAP-2, GFAP, and Olig-2.  
CONCLUSION 
NT-3 at 25 ng/ml induced the highest MSCs neural differentiation on 
day 7. Differentiation was stationary by day 14. Thus, NT-3 plays a 
role in the early stage of differentiation into neurons from MSCs in 
rat bone marrow. The NT-3 concentration at 25 ng/ml in this 
experiment setting yields optimal results for neural differentiation 
into nestin-positive cells. This information provides insight for 
tackling neuroregeneration in neurodegenerative diseases and 
should be confirmed in further investigations on a larger scale.  
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